AR and neoplasm: The specific inhibitor of Hsp90, 17-allylamino-17-demethoxygeldanamycin (17-AAG), prevents the nuclear localization of androgen receptor in AI tumor at much lower doses than that required to inhibit androgen induced nuclear import of androgen receptors (AR) (13).